Changsha, China

Honghao Zhou

This inventor holds 1 USPTO granted patent. Top assignee: Xiangya Hospital of Central South University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Honghao Zhou. Retrieved from https://idiyas.com/inventor/honghao-zhou-i6776ru5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Honghao Zhou and Pharmaceutical Research at Xiangya Hospital

Introduction

Honghao Zhou is an inventor based in Changsha, China. His patent work is associated with Xiangya Hospital of Central South University and focuses on a proposed pharmaceutical approach to colon cancer treatment.

Latest Patents

Zhou is associated with 1 patent: “Pharmaceutical Composition Comprising Sutterella Wadsworthensis and Immune Checkpoint Inhibitors for Treatment of Colon Cancer.” The patent describes a composition combining Sutterella wadsworthensis with immune checkpoint inhibitors for potential use in treating colon cancer.

Career Highlights

Zhou’s listed invention connects research at Xiangya Hospital of Central South University with the investigation of therapeutic strategies for colon cancer. The patent title indicates an approach involving both a bacterium and immune checkpoint inhibitors.

Collaborations

Wei Zhang and Yongchao Gao are identified as Zhou’s coworkers. Their names are provided in connection with his professional and research context.

Conclusion

Honghao Zhou’s patent reflects research into a combination-based approach to colon cancer treatment and his association with Xiangya Hospital of Central South University.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…